The co‑treatment of metformin with flavone synergistically induces apoptosis through inhibition of PI3K/AKT pathway in breast cancer cells

Abstract

Abstract. Metformin, a widely used antidiabetic drug, exhibits anticancer effects which are mediated by the phosphatidylinositol 3-kinase (PI3K)/serine/threonine kinase (AKT) signaling pathway. However, its use in anticancer therapy combined with other natural products remains unclear. Flavone as the core structure of flavonoids has been demonstrated to induce cell apoptosis without causing serious side effect. Murine double minute X (MDMX) inhibits tumor suppressor gene p53 whose function is associated with the PI3K/AKT pathway. The results presented herein revealed that the combination of metformin and flavone significantly inhibited cell viability, and increased apoptosis of human breast cancer cells compared with metformin or flavone alone. The combination decreased the protein expression of MDMX, activated p53 through the PI3K/AKT signaling pathway, regulated p53 downstream target genes Bcl-2 apoptosis regulator, BCL2 associated X apoptosis regulator and cleaved caspase3, subsequently inducing apoptosis in MDA-MB-231 and MCF-7 breast cancer cells. These results indicated that dietary flavone may potentiate breast cancer cell apoptosis induced by metformin, and PI3K/AKT is involved in regulating MDMX/p53 signaling. This data suggests that dietary supplementary of flavone is a promising strategy for metformin mediated anticancer effects.

Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer

“…Therefore, the reduction of the concentration and toxicity of ADM under the premise of ensuring the therapeutic effect is a key problem in the treatment of breast cancer. Recently, many kinds of combined drugs are commonly used in the treatment of tumors, and good curative effects have been achieved (Zheng et al, 2018). Treatment with a combination of ADM and Taxol (paclitaxel) is a current clinical recommendation (Ardavanis et al, 2008), but its application is hampered by the collection of the raw material for paclitaxel, whereby rare plant resources are destroyed (Gelderblom et al, 2001).…”

Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer

“…MCF10A, MCF7, MDA-MB-231 [189] Melatonin DMBA induced tumor incidence, tumor growth, and volume were reduced by the combination treatment. The apoptotic stimulation observed in the cancer cells was attributed to the activation of caspase 3.…”

Scandenolone from Cudrania tricuspidata fruit extract suppresses the viability of breast cancer cells (MCF-7) in vitro and in vivo

“…As a transcription factor, p53 targets multiple elements involved in the apoptotic pathway, including p53-regulated apoptosis-inducing protein 1 (p53AIP1) and pro-apoptotic Bcl-2 family members (Chipuk et al, 2004). Additionally, p53 is upregulated by the phosphorylation of p38 MAPK (Dewanjee et al, 2017), elevated p53 is related to the mediation of apoptosis (Zheng et al, 2018). The activated JNK can regulate a variety of transcription factors and mitochondrial proteins like Bcl-2 and Bcl-xL (Radogna et al, 2015).…”